文献速递心血管胸部CT

人工智能引导的定量斑块分期可预测有动脉粥样硬化性心血管疾病风险患者的长期心血管结局

AI-Guided Quantitative Plaque Staging Predicts Long-Term Cardiovascular Outcomes in Patients at Risk for Atherosclerotic CVD.
PubMed 文献 · JACC Cardiovasc Imaging · 2023-07-19

本研究对536例疑似冠心病患者行CCTA并采用AI-QCT分析斑块负荷,按斑块分期系统分级,随访中位10.3年。结果显示,与0期和1期相比,3期PAV患者MACE风险增加超过3倍(校正HR 3.57),非钙化斑块体积百分比>7.5%者风险增加4倍(校正HR 4.37)。AI-QCT在临床危险因素和CACS基础上可提高10年AUC(0.82 vs 0.73),并优于CAD-RADS 2.0和手动QCT。

要点

  • AI-QCT斑块分期3期(PAV>15%)与MACE风险增加超过3倍相关(校正HR 3.57)。
  • 非钙化斑块体积百分比>7.5%者MACE风险增加4倍(校正HR 4.37)。
  • AI-QCT在临床危险因素和CACS基础上提高10年AUC(0.82 vs 0.73)。

核心结论

  • 经过10年随访,AI-QCT斑块分期对MACE显示出重要预后价值,并在临床危险因素、CACS和手动指南推荐CCTA评估之上提供额外的区分能力。

研究设计与样本

  • 长期随访研究,纳入536例因疑似冠心病转诊的患者,CCTA扫描采用AI-QCT分析,斑块负荷按斑块分期系统分类(0期:0% PAV;1期:>0%-5% PAV;2期:>5%-15% PAV;3期:>15% PAV),主要终点为MACE复合终点(非致死性心肌梗死、非致死性卒中、冠状动脉血运重建和全因死亡)。

关键影像表现/征象

  • 与0期和1期相比,3期PAV患者MACE风险增加超过3倍(校正HR 3.57;95%CI 2.12-6.00;P<0.001)。
  • 与0期和1期相比,非钙化斑块体积百分比>7.5%者MACE风险增加4倍(校正HR 4.37;95%CI 2.51-7.62;P<0.001)。

诊断标准与关键数值

  • 斑块分期系统:0期:0% PAV;1期:>0%-5% PAV;2期:>5%-15% PAV;3期:>15% PAV。
  • AI-QCT联合临床危险因素和CACS的10年AUC为0.82(95%CI 0.78-0.87),优于临床危险因素和CACS模型的0.73(95%CI 0.68-0.79),P<0.001;净重分类改善为0.21(95%CI 0.09-0.38)。
  • AI-QCT的10年AUC为0.78(95%CI 0.73-0.83),优于CAD-RADS 2.0的10年AUC(P=0.023)和手动QCT的10年AUC(P=0.040),净重分类改善分别为0.09(95%CI -0.02至0.29)和0.04(95%CI -0.05至0.27)。

临床应用与阅片要点

  • AI-QCT斑块分期(尤其3期PAV>15%)和非钙化斑块体积百分比>7.5%可用于识别MACE高风险患者。
  • AI-QCT在临床危险因素和CACS基础上可提高长期风险预测的区分能力。

局限性

  • AI-QCT与CAD-RADS 2.0和手动QCT相比的净重分类改善幅度有限,分别为0.09(95%CI -0.02至0.29)和0.04(95%CI -0.05至0.27)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The recent development of artificial intelligence-guided quantitative coronary computed tomography angiography analysis (AI-QCT) has enabled rapid analysis of atherosclerotic plaque burden and characteristics.

OBJECTIVES: This study set out to investigate the 10-year prognostic value of atherosclerotic burden derived from AI-QCT and to compare the spectrum of plaque to manually assessed coronary computed tomography angiography (CCTA), coronary artery calcium scoring (CACS), and clinical risk characteristics.

METHODS: This was a long-term follow-up study of 536 patients referred for suspected coronary artery disease. CCTA scans were analyzed with AI-QCT and plaque burden was classified with a plaque staging system (stage 0: 0% percentage atheroma volume [PAV]; stage 1: >0%-5% PAV; stage 2: >5%-15% PAV; stage 3: >15% PAV). The primary major adverse cardiac event (MACE) outcome was a composite of nonfatal myocardial infarction, nonfatal stroke, coronary revascularization, and all-cause mortality.

RESULTS: The mean age at baseline was 58.6 years and 297 patients (55%) were male. During a median follow-up of 10.3 years (IQR: 8.6-11.5 years), 114 patients (21%) experienced the primary outcome. Compared to stages 0 and 1, patients with stage 3 PAV and percentage of noncalcified plaque volume of >7.5% had a more than 3-fold (adjusted HR: 3.57; 95% CI 2.12-6.00; P < 0.001) and 4-fold (adjusted HR: 4.37; 95% CI: 2.51-7.62; P < 0.001) increased risk of MACE, respectively. Addition of AI-QCT improved a model with clinical risk factors and CACS at different time points during follow-up (10-year AUC: 0.82 [95% CI: 0.78-0.87] vs 0.73 [95% CI: 0.68-0.79]; P < 0.001; net reclassification improvement: 0.21 [95% CI: 0.09-0.38]). Furthermore, AI-QCT achieved an improved area under the curve compared to Coronary Artery Disease Reporting and Data System 2.0 (10-year AUC: 0.78; 95% CI: 0.73-0.83; P = 0.023) and manual QCT (10-year AUC: 0.78; 95% CI: 0.73-0.83; P = 0.040), although net reclassification improvement was modest (0.09 [95% CI: -0.02 to 0.29] and 0.04 [95% CI: -0.05 to 0.27], respectively).

CONCLUSIONS: Through 10-year follow-up, AI-QCT plaque staging showed important prognostic value for MACE and showed additional discriminatory value over clinical risk factors, CACS, and manual guideline-recommended CCTA assessment.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Nurmohamed NS, Bom MJ, Jukema RA, et al. AI-Guided Quantitative Plaque Staging Predicts Long-Term Cardiovascular Outcomes in Patients at Risk for Atherosclerotic CVD. JACC Cardiovasc Imaging. 2023. PMID: 37480907. doi:10.1016/j.jcmg.2023.05.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。